Reapplix has developed the LeucoPatch™, which is a medical patch enhancing the inherent wound healing capability of the human body. The product is made entirely from the patient's own blood without any additives and is therefore fully autologous and biocompatible. Reapplix is focusing on chronic wounds such as Diabetic Foot Ulcers.

Help the patient heal

“Reapplix’ objective was to enable patients the benefit of their own bodies’ wound healing properties. We saw a great potential in the revolutionizing technology behind LeucoPatch™ as well as the extensive medical benefits and commercial potential of the product and treatment procedure.”

General Partner, Ulf Rosén

All investments